Highlands Oncology Group, PA — Rogers, Arkansas

Highlands Oncology Group, PA is a clinical research site located in Rogers, Arkansas, United States 72758.

Crixeo Health Trust Score: 74/100 (FAIR). This profile has not yet been claimed by the site owner.

Highlands Oncology Group, PA has participated in 8 clinical trials with 6 currently active.

Therapeutic areas: Advanced Malignancies, NSCLC, Ovarian Cancer.

Sponsors: Pfizer, University of Arkansas, Seagen, a wholly owned subsidiary of Pfizer.

Sponsor Feasibility Report

Trust Score: 74/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Highlands Oncology Group, PA?

Highlands Oncology Group, PA has a Crixeo Trust Score of 74/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Highlands Oncology Group, PA conducted?

Highlands Oncology Group, PA has 8 clinical trials on record, with 6 currently active. Their work covers Advanced Malignancies, NSCLC, Ovarian Cancer.

Is Highlands Oncology Group, PA accredited by Crixeo Health?

Yes — Highlands Oncology Group, PA holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Highlands Oncology Group, PA?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.